Acupuncture Resets Gut Signals to Fight Depression in New Mouse Study

Depression touches roughly 280 million people worldwide, yet over one-third of patients respond poorly to standard antidepressants, underscoring a genuine gap in our understanding of how the disease works. A new mouse study published in Theoretical and Natural Science by researcher Xin Chen takes an unconventional angle: it proposes that acupuncture's antidepressant effects may run through the gut, specifically through small molecules called short-chain fatty acids (SCFAs) that gut bacteria produce and that help regulate brain inflammation. The findings are early and preliminary, but the mechanistic chain they sketch is detailed enough to warrant attention.

Acupuncture at Three Points Reversed CUMS-Induced Depressive Behaviors

The study used a well-established rodent protocol called chronic unpredictable mild stress (CUMS): forty male C57BL/6J mice were exposed to four weeks of randomized, low-grade stressors combined with social isolation, a combination reliably shown to produce depression-like symptoms. Compared to unstressed controls, CUMS mice showed a significantly reduced preference for sugar water, an indicator of anhedonia; increased immobility on forced swimming and tail suspension tests; and blunted weight gain. Acupuncture was administered at three traditional points: Baihui (GV 20, at the crown of the skull), Yinzhang (GV 29, at the nasal tip), and bilateral Zusanli (ST 36, on the lower limb). Sessions used electroacupuncture at alternating 2 Hz and 15 Hz frequencies. After treatment, the CUMS-plus-acupuncture group showed systematic reversal of every behavioral deficit the stress protocol had produced.

Gut Microbiota Metabolites Dropped Under Stress and Rose With Treatment

The behavioral recovery mapped onto measurable changes in the gut. CUMS mice had significantly lower fecal levels of three key SCFAs: acetic acid, propionic acid, and butyric acid. These molecules, primary metabolites produced when gut bacteria ferment dietary fiber, are increasingly recognized as regulators of neuropsychiatric health through neural, endocrine, and immune pathways. Acupuncture treatment restored SCFA levels toward those seen in the control group. Alongside the SCFA changes, the stress model reduced expression of two tight junction proteins, ZO-1 and Occludin, that hold intestinal wall cells together. Lower expression of these proteins signals a leakier gut barrier, one that allows bacterial products to cross into the bloodstream and potentially reach the brain. Acupuncture restored ZO-1 and Occludin expression as well, suggesting it may physically repair gut wall integrity, not simply dampen downstream inflammation.

TLR4/NF-kB Inflammatory Amplification in the Hippocampus

The study's mechanistic hypothesis centers on a well-characterized inflammatory pathway. When microbial products slip through a compromised gut barrier, they can activate Toll-like receptor 4 (TLR4), a pattern-recognition receptor that triggers the NF-kB signaling cascade and drives production of pro-inflammatory cytokines. TLR4 signaling has been increasingly linked to depression pathogenesis, with the receptor appearing to regulate neuroinflammation and oxidative stress in the brain. CUMS mice in the study showed elevated TLR4 protein and phosphorylated NF-kB (p-NF-kB) in hippocampal tissue, alongside higher concentrations of the cytokines TNF-alpha, IL-1 beta, and IL-6. Acupuncture reduced all of these markers. The researchers then added a second test: combining acupuncture with TAK-242, a specific pharmacological inhibitor of TLR4. This combination further improved both behavioral scores and neuroinflammatory markers beyond what acupuncture alone achieved. Notably, the combination did not produce additional changes in upstream SCFA levels, suggesting acupuncture's effect on the gut metabolite layer is distinct from its effect on the TLR4 receptor itself.

Study Limitations and What Remains Uncertain

Several caveats are important here. The sample is small: ten mice per group. The study used only male mice, which means nothing can be said about sex-dependent effects. Rodent CUMS models capture some features of human depression but not all, and translating gut-brain axis findings from mice to people is genuinely hard. The causal direction, specifically whether falling SCFA levels drive TLR4 activation or whether stress damages the gut barrier by some other route first, is not settled by this data. Existing research on treatment-resistant depression and the microbiome-gut-brain axis emphasizes precisely this kind of complexity, noting that the relationships between microbiota composition, metabolite production, and brain function involve multiple interacting feedback loops that animal models can only partially reproduce. The study also does not sequence the gut microbiome directly, so it cannot say which bacterial species are responsible for the observed SCFA changes.

What Comes Next for Acupuncture and Gut-Brain Depression Research

Despite the preliminary nature of the evidence, the study adds a specific mechanistic layer to a body of work that has been growing steadily. Systematic reviews of acupuncture for depression have found a favorable safety profile and efficacy comparable to conventional pharmacotherapy in some populations, though most of that literature focuses on clinical outcomes rather than biological mechanisms. The gut-brain framing here opens several testable questions: Does electroacupuncture change gut microbiota composition, and if so, which taxa shift? Can butyrate supplementation replicate the antidepressant effects seen when acupuncture restores SCFA levels? Would TLR4 inhibition alone, without acupuncture, produce a similar behavioral benefit in CUMS animals? Answering those questions will require larger studies, microbiome sequencing, and eventually human trials before any clinical claims can be made. For now, this research represents a carefully constructed early-stage hypothesis, one that connects a two-thousand-year-old practice to a molecular pathway that contemporary neuroscience is actively investigating.

Evidence rating

INVESTIGATIONAL — 71/100

Caveats:

• Funding source was not disclosed by the authors.
• No microbiome sequencing was performed, so the specific bacterial species driving SCFA changes cannot be identified.
• Results are from a mouse model only and may not translate to humans.

This is a controlled animal study using 40 male mice (n=10 per group), examining electroacupuncture effects on gut-brain axis markers in a chronic stress depression model. Results show associations between acupuncture, SCFA restoration, intestinal barrier repair, and reduced hippocampal neuroinflammation, but causal directionality is inferred rather than established — no microbiome sequencing, gene knockout, or fecal transplant experiments were performed to confirm the SCFA source or mechanism. Findings have not been replicated in independent studies or in human populations.

References

1. Xin Chen (2026). Acupuncture Ameliorates Depressive-Like Behaviors Via SCFA-Mediated TLR4 Signaling in the Gut-Brain Axis. Theoretical and Natural Science. https://doi.org/10.54254/2753-8818/2026.34696
2. Junzhe Cheng, Hongkun Hu, Yumeng Ju, et al. (2024). Gut microbiota‐derived short‐chain fatty acids and depression: deep insight into biological mechanisms and potential applications. General Psychiatry. https://doi.org/10.1136/gpsych-2023-101374
3. Lin Tan, Jiayue Li, Dingcheng Sun, Xinyi Tian, Xiaoli Zhong, Yiyi Shan (2025). TLR4 as a therapeutic target: Antidepressant mechanism of saikosaponin A in regulating the NF-κB/BDNF axis and mitigating oxidative stress and inflammation in vivo and in vitro. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2025.1585290
4. Zhangcheng Zhu, Yiwen Cheng, Xia Liu, et al. (2025). The microbiota-gut-brain axis in depression: unraveling the relationships and therapeutic opportunities. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2025.1644160
5. Yawen Tan, Ruqian Duan, Chuanbiao Wen (2024). Efficacy of acupuncture for depression: a systematic review and meta-analysis. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2024.1347651